A high circulating osteoprotegerin (OPG) level may be a risk factor for vascular calcification
and mortality in hemodialysis patients. OPG and pulse wave velocity (PWV) were measured …

Background. Osteoprotegerin (OPG) is a marker and regulator of arterial calcification, and it
is related to cardiovascular survival in haemodialysis patients. The link between OPG and …

Methods We conducted a prospective observational study in 97 HD patients. OPG and fetuin-
A were measured at baseline and arterial stiffness was evaluated by PWV. All patients were …

Background To assess whether serum osteoprotegerin (OPG) and/or fetuin-A predict
mortality and cardiovascular (CV) morbidity and mortality in hemodialysis patients. Methods …

Background: Patients on hemodialysis (HD) frequently experience cardiovascular events
associated with vascular calcification. We investigated the involvement of osteoprotegerin …

Background Osteoprotegerin (OPG) plays protective roles against the development of
vascular calcification (VC) which greatly contributes to the increased cardiovascular events …

Background: Patients treated with hemodialysis (HD) have an increased mortality, mainly
caused by cardiovascular disease (CVD). Osteoprotegerin (OPG) is a glycoprotein involved …

Expression of bone proteins resulting from transdifferentiation of vascular smooth muscle
cells into osteoblasts suggests that vascular calcifications are a bioactive process …

Background: The aim of this prospective cohort study was to evaluate the progression of
coronary artery calcification (CAC), and atherosclerosis in hemodialysis (HD) patients and to …

Background Cardiovascular morbidity and mortality are highly prevalent in patients with end-
stage renal disease, and osteoprotegerin (OPG) may be an important link between bone …